Aripiprozole-induced diplopia: A case report
Küçük Resim Yok
Tarih
2013
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Diplopi çift görme olarak tanımlanan ve yaşam kalitesini bozan bir durumdur. Akut diplopi bazı genel tıbbi ilaçlar ve psikotrop ilaç kullanımında görülmektedir. Aripiprazol D2 ve 5-HT1A reseptörlerine parsiyel agonist ve 5-HT2A reseptörlerine antagonist aktivite gösteren atipik antipsikotik ajandır. Bu yazıda şizofreniform bozukluk tanısıyla takip edilen 24 yaşındaki bir hastada, oral aripiprazol kullanımını takiben ortaya çıkan, diplopi olgusu bildirilmektedir. Klinisyenler aripiprazol tedavisiyle diplopi ortaya çıkabileceğini akılda tutmalıdırlar.
Diplopia is a condition that involves seeing double and impairs quality of life. Acute diplopia can be seen with some general medical drugs and psychotropic drugs. Aripiprazole is a new atypical antipsychotic agent; it has partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors. This paper reports development of diplopia, a rare adverse effect of psychotropic drugs, in a 24 year old patient with schizophreniform disorder following use of oral aripiprazole. Clinicians should keep in mind that diplopia may occur with aripiprazole treatment.
Diplopia is a condition that involves seeing double and impairs quality of life. Acute diplopia can be seen with some general medical drugs and psychotropic drugs. Aripiprazole is a new atypical antipsychotic agent; it has partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors. This paper reports development of diplopia, a rare adverse effect of psychotropic drugs, in a 24 year old patient with schizophreniform disorder following use of oral aripiprazole. Clinicians should keep in mind that diplopia may occur with aripiprazole treatment.
Açıklama
Anahtar Kelimeler
Farmakoloji ve Eczacılık
Kaynak
Klinik Psikofarmakoloji Bülteni
WoS Q Değeri
Scopus Q Değeri
Cilt
23
Sayı
4
